Jesús Mantas serves as an Independent Director and Chair of the Compensation and Management Development Committee in the Board of Biogen (NASDAQ:BIIB), a leading biotechnology company focused on neuroscience. He also serves as a member of the Audit Committee. He is also the Global Managing Partner in IBM Consulting responsible for Business Transformation Services, leading the $10B unit transforming and operating mission critical businesses with digital technology and AI. In his prior role as Global Managing Partner of Strategy, Innovation and Corporate Development, he defined the new IBM Consulting market strategy, offerings, ecosystem, acquisition and thought leadership, and led its successful execution. He previously held multiple leadership roles in IBM as General Manager of IBM Business Process Outsourcing, General Manager of IBM Consulting in Latin America, and Managing Partner of North America Enterprise Market among others. Jesus is known for his ability to innovate, his track record transforming global businesses, develop leadership and change culture. He is also known for his advocacy for the Hispanic community, behavior science and brain health. Before joining IBM, Jesus was a partner in the High

Technology Practice of PricewaterhouseCoopers Consulting. He also worked for Ernst & Young and lead supply chain systems for Procter & Gamble in Spain. In addition to his service in the board of Biogen, he serves on the boards of HITEC and NACME, non-profits focused on leadership development and diversity in technology careers. He is a Limited Partner in a few investment funds and was also a founding member of the World Economic Forum's Global AI Council. Jesus holds degrees in Telecommunications, and Business Administration by Universidad Politécnica de Madrid, was an adjunct professor at the MBA program of the University of California, Irvine; and he served as an officer in the Air Force of Spain.